Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2001. Start Trial.
Date Value
June 30, 2023 -38.88M
March 31, 2023 -41.47M
December 31, 2022 -42.43M
September 30, 2022 -43.25M
June 30, 2022 -41.71M
March 31, 2022 -40.68M
December 31, 2021 -40.62M
September 30, 2021 -39.41M
June 30, 2021 -39.43M
March 31, 2021 -37.43M
December 31, 2020 -35.74M
September 30, 2020 -36.10M
June 30, 2020 -38.04M
March 31, 2020 -37.63M
December 31, 2019 -41.53M
September 30, 2019 -16.30M
June 30, 2019 -13.47M
March 31, 2019 -11.13M
December 31, 2018 -4.714M
September 30, 2018 -19.86M
June 30, 2018 -23.91M
March 31, 2018 -28.79M
December 31, 2017 -36.71M
September 30, 2017 -58.89M
June 30, 2017 -82.94M
Date Value
March 31, 2017 -119.66M
December 31, 2016 -154.36M
September 30, 2016 -50.62M
June 30, 2016 -57.12M
March 31, 2016 -42.54M
December 31, 2015 -83.65M
September 30, 2015 -220.07M
June 30, 2015 59.76M
March 31, 2015 68.28M
December 31, 2014 117.72M
September 30, 2014 134.89M
June 30, 2014 -129.74M
March 31, 2014 -132.16M
December 31, 2013 -113.91M
September 30, 2013 -113.52M
June 30, 2013 -117.54M
March 31, 2013 -94.22M
December 31, 2012 -80.14M
September 30, 2012 -52.60M
June 30, 2012 -29.12M
March 31, 2012 -35.18M
December 31, 2011 -33.11M
September 30, 2011 -33.02M
June 30, 2011 -35.17M
March 31, 2011 -32.57M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
MabCure, Inc. --
Adynxx, Inc. --
OncoSec Medical, Inc. --
Proteonomix, Inc. --
Rebus Holdings, Inc. --